{"ticker": "CLBS", "overview": {"cik": "320017", "ticker": "LSTA", "name": "LISATA THERAPEUTICS, INC.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "ARS", "date": "2026-10-19", "title": "Form ARS", "accession": "0001140361-26-040000", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-10-19", "title": "Proxy statement", "accession": "0001140361-26-039986", "price_sensitive": false}, {"form": "3", "date": "2026-10-15", "title": "FORM 3", "accession": "0001140361-26-039795", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-14", "title": "Material event", "accession": "0001140361-26-039602", "price_sensitive": true}, {"form": "PRE 14A", "date": "2026-10-07", "title": "Form PRE 14A", "accession": "0001140361-26-038937", "price_sensitive": false}, {"form": "D", "date": "2026-10-02", "title": "Form D", "accession": "0000320017-26-000039", "price_sensitive": false}, {"form": "3", "date": "2026-09-28", "title": "FORM 3", "accession": "0001140361-26-037879", "price_sensitive": false}, {"form": "3", "date": "2026-09-28", "title": "FORM 3", "accession": "0001140361-26-037878", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-17", "title": "Material event", "accession": "0001140361-26-036866", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-08-26", "title": "Form SCHEDULE 13G", "accession": "0002150037-26-000001", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-06", "title": "Quarterly report", "accession": "0000320017-26-000038", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-04", "title": "Material event", "accession": "0001140361-26-031028", "price_sensitive": true}, {"form": "SC TO-T/A", "date": "2026-07-28", "title": "Form SC TO-T/A", "accession": "0001140361-26-029893", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-24", "title": "Material event", "accession": "0001140361-26-029541", "price_sensitive": true}, {"form": "SC 14D9/A", "date": "2026-07-21", "title": "Form SC 14D9/A", "accession": "0001140361-26-029022", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "Material event", "accession": "0001140361-26-028763", "price_sensitive": true}, {"form": "SC 14D9/A", "date": "2026-07-17", "title": "Form SC 14D9/A", "accession": "0001140361-26-028761", "price_sensitive": false}, {"form": "SC TO-T/A", "date": "2026-07-17", "title": "Form SC TO-T/A", "accession": "0001140361-26-028733", "price_sensitive": false}, {"form": "SC 14D9/A", "date": "2026-07-13", "title": "Form SC 14D9/A", "accession": "0001140361-26-028257", "price_sensitive": false}, {"form": "SC TO-T/A", "date": "2026-07-10", "title": "SCHEDULE TO-T/A", "accession": "0001140361-26-028238", "price_sensitive": false}, {"form": "SC 14D9/A", "date": "2026-07-02", "title": "Form SC 14D9/A", "accession": "0001140361-26-027435", "price_sensitive": false}, {"form": "SC 14D9", "date": "2026-06-10", "title": "Form SC 14D9", "accession": "0001140361-26-024737", "price_sensitive": false}, {"form": "SC TO-T", "date": "2026-06-10", "title": "Form SC TO-T", "accession": "0001140361-26-024731", "price_sensitive": false}, {"form": "SC14D9C", "date": "2026-06-09", "title": "Form SC14D9C", "accession": "0001140361-26-024561", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-09", "title": "Material event", "accession": "0001140361-26-024560", "price_sensitive": true}]}, "description": "CLBS trades as CLBS. Privy Trades holds 152 insider filings for the company, from August 2015 to December 2021. Across those, 5 insiders disclosed 5 open-market purchases totalling $274.91K against 7 sales totalling $222.64K. The most recent filing on record is dated 1 September 2022.", "exchange": null, "stats": {"buy_n": 5, "buy_sum": 274911.3325, "sell_n": 7, "sell_sum": 222642.3509, "net": 52268.98160000003, "insiders": 5, "first_date": "2015-08-11", "last_date": "2021-12-08"}, "metrics": {"ticker": "CLBS", "has_prices": false}, "trades": [{"id": "0001334549-22-000007", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 109871.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000133454922000007/0001334549-22-000007-index.htm", "trade_date": "2022-09-01", "timestamp": "2022-09-01", "mins": 2194061}, {"id": "0001879231-22-000006", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Kristen K. Buck", "who_key": "Buck Kristen K", "role": "EVP, R&D and CMO", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 63979.5, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000187923122000006/0001879231-22-000006-index.htm", "trade_date": "2022-09-01", "timestamp": "2022-09-01", "mins": 2194061}, {"id": "0001891257-22-000004", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Todd C. Girolamo", "who_key": "Girolamo Todd C", "role": "CLO, SVP of Corp Dev", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 3836.9700999999995, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000189125722000004/0001891257-22-000004-index.htm", "trade_date": "2022-01-14", "timestamp": "2022-01-14", "mins": 2525261}, {"id": "0001334549-22-000004", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 10641.2317, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000133454922000004/0001334549-22-000004-index.htm", "trade_date": "2022-01-14", "timestamp": "2022-01-14", "mins": 2525261}, {"id": "0001891257-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Todd C. Girolamo", "who_key": "Girolamo Todd C", "role": "CLO, SVP of Corp Dev", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 20045.3872, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000189125722000002/0001891257-22-000002-index.htm", "trade_date": "2022-01-11", "timestamp": "2022-01-11", "mins": 2529581}, {"id": "0001334549-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 66209.744, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000133454922000002/0001334549-22-000002-index.htm", "trade_date": "2022-01-11", "timestamp": "2022-01-11", "mins": 2529581}, {"id": "0001373585-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Gregory B. Brown", "who_key": "BROWN GREGORY B", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000137358522000002/0001373585-22-000002-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001573785-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Michael H. Davidson", "who_key": "Davidson Michael H.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000157378522000002/0001573785-22-000002-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001741455-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Cynthia Louise Flowers", "who_key": "Flowers Cynthia Louise", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000174145522000002/0001741455-22-000002-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001192621-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Steven M. Klosk", "who_key": "KLOSK STEVEN M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000119262122000002/0001192621-22-000002-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001078274-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Steven S. Myers", "who_key": "MYERS STEVEN S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000107827422000002/0001078274-22-000002-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001284500-22-000003", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Peter G. Traber", "who_key": "TRABER PETER G", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000128450022000003/0001284500-22-000003-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001593283-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Anne Clem Whitaker", "who_key": "Whitaker Anne Clem", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000159328322000002/0001593283-22-000002-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001879231-22-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Kristen K. Buck", "who_key": "Buck Kristen K", "role": "EVP, R&D and CMO", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 7055.398, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000187923122000002/0001879231-22-000002-index.htm", "trade_date": "2022-01-10", "timestamp": "2022-01-10", "mins": 2531021}, {"id": "0001078274-21-000006", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Steven S. Myers", "who_key": "MYERS STEVEN S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 30190.275999999998, "score": 37.4, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CLBS lands a director's $30K", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000107827421000006/0001078274-21-000006-index.htm", "trade_date": "2021-12-08", "timestamp": "2021-12-08", "mins": 2578541}, {"id": "0001879231-21-000006", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Kristen K. Buck", "who_key": "Buck Kristen K", "role": "EVP, R&D and CMO", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 64131.840000000004, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000187923121000006/0001879231-21-000006-index.htm", "trade_date": "2021-09-01", "timestamp": "2021-09-01", "mins": 2719661}, {"id": "0001334549-21-000005", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 52988.759999999995, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000133454921000005/0001334549-21-000005-index.htm", "trade_date": "2021-01-14", "timestamp": "2021-01-14", "mins": 3050861}, {"id": "0001334549-21-000002", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 33988.990000000005, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000133454921000002/0001334549-21-000002-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001373585-21-000003", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Gregory B. Brown", "who_key": "BROWN GREGORY B", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000137358521000003/0001373585-21-000003-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001573785-21-000005", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Michael H. Davidson", "who_key": "Davidson Michael H.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000157378521000005/0001573785-21-000005-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001192621-21-000003", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Steven M. Klosk", "who_key": "KLOSK STEVEN M", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000119262121000003/0001192621-21-000003-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001078274-21-000003", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Steven S. Myers", "who_key": "MYERS STEVEN S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000107827421000003/0001078274-21-000003-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001741455-21-000003", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Cynthia Schwalm", "who_key": "Schwalm Cynthia", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000174145521000003/0001741455-21-000003-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001284500-21-000003", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Peter G. Traber", "who_key": "TRABER PETER G", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000128450021000003/0001284500-21-000003-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001593283-21-000005", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Anne Clem Whitaker", "who_key": "Whitaker Anne Clem", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000159328321000005/0001593283-21-000005-index.htm", "trade_date": "2021-01-11", "timestamp": "2021-01-11", "mins": 3055181}, {"id": "0001104659-20-121061", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Anne Clem Whitaker", "who_key": "Whitaker Anne Clem", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 119999.7, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000110465920121061/0001104659-20-121061-index.htm", "trade_date": "2020-11-01", "timestamp": "2020-11-01", "mins": 3157421}, {"id": "0001573785-20-000017", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Michael H. Davidson", "who_key": "Davidson Michael H.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 99945.0, "score": 54.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board member picks up $100K of CLBS", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000157378520000017/0001573785-20-000017-index.htm", "trade_date": "2020-09-09", "timestamp": "2020-09-09", "mins": 3233741}, {"id": "0001573785-20-000014", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Michael H. Davidson", "who_key": "Davidson Michael H.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 119998.05, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000157378520000014/0001573785-20-000014-index.htm", "trade_date": "2020-07-28", "timestamp": "2020-07-28", "mins": 3295661}, {"id": "0001583810-20-000006", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Douglas W. Losordo", "who_key": "LOSORDO DOUGLAS W", "role": "See Remarks", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 15933.48, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000158381020000006/0001583810-20-000006-index.htm", "trade_date": "2020-01-14", "timestamp": "2020-01-14", "mins": 3577901}, {"id": "0001334549-20-000005", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 42058.03999999999, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on CLBS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000133454920000005/0001334549-20-000005-index.htm", "trade_date": "2020-01-14", "timestamp": "2020-01-14", "mins": 3577901}], "recent_buys": [{"id": "0001078274-21-000006", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Steven S. Myers", "who_key": "MYERS STEVEN S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 30190.275999999998, "score": 37.4, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CLBS lands a director's $30K", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000107827421000006/0001078274-21-000006-index.htm", "trade_date": "2021-12-08", "timestamp": "2021-12-08", "mins": 2578541}, {"id": "0001573785-20-000017", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "CALADRIUS BIOSCIENCES, INC.", "who": "Michael H. Davidson", "who_key": "Davidson Michael H.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 99945.0, "score": 54.0, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Board member picks up $100K of CLBS", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000157378520000017/0001573785-20-000017-index.htm", "trade_date": "2020-09-09", "timestamp": "2020-09-09", "mins": 3233741}, {"id": "0001144204-15-050487", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "Caladrius Biosciences, Inc.", "who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 27921.999999999996, "score": 43.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "3 insiders pile into CLBS", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415050487/0001144204-15-050487-index.htm", "trade_date": "2015-08-17", "timestamp": "2015-08-17", "mins": 5897741}, {"id": "0001144204-15-048795", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "Caladrius Biosciences, Inc.", "who": "Robert S. Vaters", "who_key": "VATERS ROBERT S", "role": "President & CFO, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 16681.356499999998, "score": 38.3, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders pile into CLBS", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415048795/0001144204-15-048795-index.htm", "trade_date": "2015-08-12", "timestamp": "2015-08-12", "mins": 5904941}, {"id": "0001144204-15-048105", "src": "INSIDERS", "ticker": "CLBS", "cik": "320017", "company": "LISATA THERAPEUTICS, INC.", "company_raw": "Caladrius Biosciences, Inc.", "who": "Robert S. Vaters", "who_key": "VATERS ROBERT S", "role": "President & CFO, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 100172.7, "score": 55.5, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "5 insiders now buying CLBS", "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415048105/0001144204-15-048105-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906381}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Eric Wei", "who_key": "Wei Eric", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 222642.3509, "net": -222642.3509, "trades": 7, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 31375.242499999997, "date": "2017-02-07", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420417006741/0001144204-17-006741-index.htm"}, {"action": "SELL", "amount": 38829.235, "date": "2017-02-06", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420417006290/0001144204-17-006290-index.htm"}, {"action": "SELL", "amount": 2100.0, "date": "2016-11-21", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420416136487/0001144204-16-136487-index.htm"}, {"action": "SELL", "amount": 52773.1734, "date": "2016-07-01", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420416111512/0001144204-16-111512-index.htm"}, {"action": "SELL", "amount": 12483.900000000001, "date": "2016-06-24", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420416109998/0001144204-16-109998-index.htm"}, {"action": "SELL", "amount": 42540.4, "date": "2016-06-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420416107350/0001144204-16-107350-index.htm"}, {"action": "SELL", "amount": 42540.4, "date": "2016-03-06", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420416107135/0001144204-16-107135-index.htm"}], "latest": {"action": "SELL", "amount": 31375.242499999997, "date": "2017-02-07", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420417006741/0001144204-17-006741-index.htm"}}, {"who": "Robert S. Vaters", "who_key": "VATERS ROBERT S", "role": "President & CFO, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 116854.05649999999, "sold": 0, "net": 116854.05649999999, "trades": 2, "top_score": 55.5, "lean": "buying", "history": [{"action": "BUY", "amount": 16681.356499999998, "date": "2015-08-12", "score": 38.3, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415048795/0001144204-15-048795-index.htm"}, {"action": "BUY", "amount": 100172.7, "date": "2015-08-11", "score": 55.5, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415048105/0001144204-15-048105-index.htm"}], "latest": {"action": "BUY", "amount": 16681.356499999998, "date": "2015-08-12", "score": 38.3, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415048795/0001144204-15-048795-index.htm"}}, {"who": "Michael H. Davidson", "who_key": "Davidson Michael H.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 99945.0, "sold": 0, "net": 99945.0, "trades": 1, "top_score": 54.0, "lean": "buying", "history": [{"action": "BUY", "amount": 99945.0, "date": "2020-09-09", "score": 54.0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000157378520000017/0001573785-20-000017-index.htm"}], "latest": {"action": "BUY", "amount": 99945.0, "date": "2020-09-09", "score": 54.0, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000157378520000017/0001573785-20-000017-index.htm"}}, {"who": "Steven S. Myers", "who_key": "MYERS STEVEN S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 30190.275999999998, "sold": 0, "net": 30190.275999999998, "trades": 1, "top_score": 37.4, "lean": "buying", "history": [{"action": "BUY", "amount": 30190.275999999998, "date": "2021-12-08", "score": 37.4, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000107827421000006/0001078274-21-000006-index.htm"}], "latest": {"action": "BUY", "amount": 30190.275999999998, "date": "2021-12-08", "score": 37.4, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000107827421000006/0001078274-21-000006-index.htm"}}, {"who": "David J. Mazzo", "who_key": "Mazzo David J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 27921.999999999996, "sold": 0, "net": 27921.999999999996, "trades": 1, "top_score": 43.8, "lean": "buying", "history": [{"action": "BUY", "amount": 27921.999999999996, "date": "2015-08-17", "score": 43.8, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415050487/0001144204-15-050487-index.htm"}], "latest": {"action": "BUY", "amount": 27921.999999999996, "date": "2015-08-17", "score": 43.8, "source_url": "https://www.sec.gov/Archives/edgar/data/320017/000114420415050487/0001144204-15-050487-index.htm"}}], "activity": [], "announcements": [{"form": "ARS", "date": "2026-10-19", "title": "Form ARS", "accession": "0001140361-26-040000", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-10-19", "title": "Proxy statement", "accession": "0001140361-26-039986", "price_sensitive": false}, {"form": "3", "date": "2026-10-15", "title": "FORM 3", "accession": "0001140361-26-039795", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-14", "title": "Material event", "accession": "0001140361-26-039602", "price_sensitive": true}, {"form": "PRE 14A", "date": "2026-10-07", "title": "Form PRE 14A", "accession": "0001140361-26-038937", "price_sensitive": false}, {"form": "D", "date": "2026-10-02", "title": "Form D", "accession": "0000320017-26-000039", "price_sensitive": false}, {"form": "3", "date": "2026-09-28", "title": "FORM 3", "accession": "0001140361-26-037879", "price_sensitive": false}, {"form": "3", "date": "2026-09-28", "title": "FORM 3", "accession": "0001140361-26-037878", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-17", "title": "Material event", "accession": "0001140361-26-036866", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-08-26", "title": "Form SCHEDULE 13G", "accession": "0002150037-26-000001", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-06", "title": "Quarterly report", "accession": "0000320017-26-000038", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-04", "title": "Material event", "accession": "0001140361-26-031028", "price_sensitive": true}, {"form": "SC TO-T/A", "date": "2026-07-28", "title": "Form SC TO-T/A", "accession": "0001140361-26-029893", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-24", "title": "Material event", "accession": "0001140361-26-029541", "price_sensitive": true}, {"form": "SC 14D9/A", "date": "2026-07-21", "title": "Form SC 14D9/A", "accession": "0001140361-26-029022", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "Material event", "accession": "0001140361-26-028763", "price_sensitive": true}, {"form": "SC 14D9/A", "date": "2026-07-17", "title": "Form SC 14D9/A", "accession": "0001140361-26-028761", "price_sensitive": false}, {"form": "SC TO-T/A", "date": "2026-07-17", "title": "Form SC TO-T/A", "accession": "0001140361-26-028733", "price_sensitive": false}, {"form": "SC 14D9/A", "date": "2026-07-13", "title": "Form SC 14D9/A", "accession": "0001140361-26-028257", "price_sensitive": false}, {"form": "SC TO-T/A", "date": "2026-07-10", "title": "SCHEDULE TO-T/A", "accession": "0001140361-26-028238", "price_sensitive": false}, {"form": "SC 14D9/A", "date": "2026-07-02", "title": "Form SC 14D9/A", "accession": "0001140361-26-027435", "price_sensitive": false}, {"form": "SC 14D9", "date": "2026-06-10", "title": "Form SC 14D9", "accession": "0001140361-26-024737", "price_sensitive": false}, {"form": "SC TO-T", "date": "2026-06-10", "title": "Form SC TO-T", "accession": "0001140361-26-024731", "price_sensitive": false}, {"form": "SC14D9C", "date": "2026-06-09", "title": "Form SC14D9C", "accession": "0001140361-26-024561", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-09", "title": "Material event", "accession": "0001140361-26-024560", "price_sensitive": true}], "performance": {"ticker": "CLBS", "has_prices": false, "summary": null, "buys": [{"who": "MYERS STEVEN S", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 30190.275999999998, "date": "2021-12-08", "score": 37.4, "ref_price": null, "return": null}, {"who": "Davidson Michael H.", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 99945.0, "date": "2020-09-09", "score": 54.0, "ref_price": null, "return": null}, {"who": "Mazzo David J", "person_type": "CEO", "person_label": "CEOs", "role": "Chief Executive Officer, Director", "amount": 27921.999999999996, "date": "2015-08-17", "score": 43.8, "ref_price": null, "return": null}, {"who": "VATERS ROBERT S", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "President & CFO, Director", "amount": 16681.356499999998, "date": "2015-08-12", "score": 38.3, "ref_price": null, "return": null}, {"who": "VATERS ROBERT S", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "President & CFO, Director", "amount": 100172.7, "date": "2015-08-11", "score": 55.5, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}